The prevalence of inflammatory bowel diseases, microscopic colitis, and colorectal cancer in patients with irritable bowel syndrome

Gastroenterology Insights

Volumn 3, Issue 1, 2011, Pages

  El Salhy, Magdy ^a,b   Halwe, Jörg ^a   Lomholt Beck, Bjarne ^c   Gundersen, Doris ^d  

^a Stord Helse Fonna Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Haugesund Helse Fonna Hospital   (Norway)

^d Helse Fonna ^*  (Norway)

Author keywords

Colorectal cancer; Crohn's disease; Histopathology; Immunocytochemistry; Irritable bowel syndrome; Microscopic colitis prevalence; Screening

Indexed keywords

AGED; ARTICLE; COLON ADENOCARCINOMA; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; IRRITABLE COLON; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; PATIENT CARE; PREVALENCE; SYMPTOM; ULCERATIVE COLITIS; ADULT; COLLAGENOUS COLITIS; COLONOSCOPY; HUMAN TISSUE; PATIENT IDENTIFICATION;

EID: 80052253715     PISSN: None     EISSN: 20367422     Source Type: Journal    
DOI: 10.4081/gi.2011.e3     Document Type: Article

References (38)

1. Thompson WG. A world view of IBS. In Irritable Bowel Syndrome: Diagnosis and Treatment. Camilleri M, Spiller R. eds. New York: Saunders, 2002, pp 17-26.
2. Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991;100:998-1005.
3. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
4. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
5. Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 2005;34:235-45.
6. Burgman T, Clara I, Graff L, et al. The Manitoba inflammatory bowel disease. Cohort study: prolonged symptoms before diagnosis - how much is irritable bowel syndrome? Clin Gastroenterol Hepatol 2006;4:614-20.
7. El-Salhy M, Stenling R, Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993;28:809-15.
8. Pardi DS, Smyrk TC, Termaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002;97:794-802.
9. American College of Gastroenterology Task Force on Irritable Bowel Syndrome: An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104:S1-35.
10. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176-8.
11. van der Wounden EJ, Karrenbeld A, Kleibeuker JH, Dijkstra G. Microscopic colitis: an unfamiliar but treatable disease. Neth J Med 2009;67:41-5.
12. Francis CY, Duffy JN, Whorwell JA, Martin DF. Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 1996;91:1348-50.
13. Hamm LR, Sorrells SC, Harding JP, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999;94:1279-82.
14. Vanner SJ, Depew WT, Paterson WG, et al. Predictive values of the Rome criteria for diagnosing irritable bowel syndrome. Am J Gastroenterol 1999;94:2912-7.
15. MacIntosh DG, Thompson WG, Patel DG, Barr R, Guindi M. Is rectal biopsy necessary in irritable bowel syndrome? Am J Gastroenterol 1992;87:1407-9.
16. Chey WD, Nojkov B, Rubenstein JH, et. al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010;105:859-65.
17. Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-81.
18. Barta Z, Mekkel G, Cspo J, et al. Microscopic colitis: a retrospective study of clinical presentation in 53 patients. World J Gastroenterol 2005;11:1351-5.
19. Madisch A, Bethke B, Stolte M, Miehlke S. Is there an association of microscopic col -itis and irritable bowel syndrome? A subgroup analysis of placebo-controlled trial. World J Gastroenterol 2005;11:6409.
20. Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from health maintenance organ -ization experience. World J Gastroenterol 2009;15:3122-7.
21. Yantiss R, Odze R. Optimal approach to obtain mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009; 104:774-83.
22. Fissora Cl, Koch KL. Symptom overlap and comorbidity of irritable bowel syndrome with other conditions. Curr Gastroenterol Rep 2005;7:264-71.
23. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504-8.
24. Ziper RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in nationwide patient support group. Dig Dis Sci 2003;48:761-4.
25. Wahnscaffe U, Ulrich R, Rieken EO, Sculzke JD. Celiac disease-like abnormal -ities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001;121:1329-38.
26. Bottaro G, Calado F, Rotolo N, Spina M, Corazza GR. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol 1999;94:691-6.
27. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001;96:126-31.
28. Makharia GK, Baba CS, Khadgawat R, et al. Celiac disease: variations of presentation in adults. Indian J Gastroenterol 2007;26:162-6.
29. Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci 2003;48:395-8.
30. El-Salhy M, Lomholt-Beck B, Gundersen D. The prevalence of celiac disease in patients with irritable bowel syndrome. Mol Med Rep 2011;4:403-5.
31. Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP and IBD antibodies. Inflamm Bowel Dis 2008;14:32-9.
32. Schuster MM. Defining and diagnosing irritable bowel syndrome. Am J Manag Care 2001;7:S246-51.
33. National Ambulatory Medical Care Survey. National Center for Health Statistics: NAMCS Description. Available from: http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm.
34. Mitchell CM, Drossman DA. Survey of AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987;92:1282-4.
35. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009;11: 265-9.
36. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109: 1736-41.
37. American Gastroenterological Association. The Burden of Gastrointestinal Diseases. 2001.
38. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122:1500-11.